We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$533M
AUM Growth
+$47.9M
Cap. Flow
-$8.36M
Cap. Flow %
-1.57%
Top 10 Hldgs %
100%
Holding
9
New
3
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
SDS icon
ProShares UltraShort S&P500
SDS
+$4.18M
2
SPXU icon
ProShares UltraPro Short S&P 500
SPXU
+$3.8M
3
SQQQ icon
ProShares UltraPro Short QQQ
SQQQ
+$3.53M

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$19.9M
2
CLDX icon
Celldex Therapeutics
CLDX
+$5

Sector Composition

Rank Sector Weight
1 Healthcare 94.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$359M 67.36%
15,094,495
-871,543
-5% -$19.9M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$108M 20.17%
2,679,835
– –
ALKS icon
3
Alkermes
ALKS
$8.82B
$32.6M 6.11%
892,400
– –
INDA icon
4
iShares MSCI India ETF
INDA
$6.71B
$11.3M 2.12%
320,000
– –
EPI icon
5
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$10.5M 1.97%
400,000
– –
SDS icon
6
ProShares UltraShort S&P500
SDS
$406M
$3.83M 0.72%
+4,600
New +$4.18M
SPXU icon
7
ProShares UltraPro Short S&P 500
SPXU
$436M
$3.31M 0.62%
+1,050
New +$3.8M
SQQQ icon
8
ProShares UltraPro Short QQQ
SQQQ
$2.21B
$2.9M 0.54%
+114
New +$3.53M
CLDX icon
9
Celldex Therapeutics
CLDX
$2.77B
$2.07M 0.39%
420,846
-1
-0% -$5

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q1 2019 Portfolio in Review

As of Q1 2019, Meditor Group held 9 positions worth $533M, up 9.9% from $485M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group's Q1 2019 filing shows 3 new and 2 reduced positions. Its largest new stake was ProShares UltraShort S&P500: 4,600 shares worth $3.83M. The largest sale was Exelixis, an estimated $19.9M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 96% a quarter earlier.

  • Meditor Group's largest Q1 2019 buy was ProShares UltraShort S&P500: 4,600 shares worth $3.83M.
  • Meditor Group's biggest Q1 2019 reduction was Exelixis, cutting an estimated $19.9M.
  • Meditor Group's ten largest holdings make up 100% of its $533M portfolio in Q1 2019.
  • Meditor Group opened 3 new positions and closed 0 in Q1 2019.
  • Meditor Group's portfolio value rose 9.9% quarter-over-quarter to $533M.

Based on Meditor Group's 13F filing for Q1 2019, filed 3 Apr 2019.